Systemic sclerosis (scleroderma): open trials in Japan

1 open trial has a site in Japan. Registry data; only the trial team decides who can take part.

NCT05878717
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Trial Treatment · Phase 2/3 · GlaxoSmithKline
GSK Investigational Site, Gunma · GSK Investigational Site, Hiroshima · GSK Investigational Site, Hokkaido · GSK Investigational Site, Kanagawa · GSK Investigational Site, Miyagi · GSK Investigational Site, Shizuoka · GSK Investigational Site, Tokushima · GSK Investigational Site, Tokyo
Registry updated 2026-09-08

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease